Public funding of pharmaceuticals in the Netherlands: investigating the effect of evidence, process and context on CVZ decision-making-Reference-Cited by-同舟云学术

Public funding of pharmaceuticals in the Netherlands: investigating the effect of evidence, process and context on CVZ decision-making

Published:2013-07-18 Issue:7 Volume:15 Page:681-695
ISSN:1618-7598
Container-title:The European Journal of Health Economics
language:en
Short-container-title:Eur J Health Econ

Author:

Cerri Karin H.,Knapp Martin,Fernandez Jose-Luis

Publisher

Springer Science and Business Media LLC

Subject

Health Policy,Economics, Econometrics and Finance (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1007/s10198-013-0514-z.pdf

Reference33 articles.

1. College voor zorgverzekeringen: CVZ-criteria voor beoordeling therapeutische waarde. http://www.fk.cvz.nl/ (2010)

2. College voor zorgverzekeringen: procedure beoordeling extramurale geneesmiddelen. http://www.fk.cvz.nl/ (2010)

3. Stolk E.A., Rutten F.F.: The “health benefit basket” in the Netherlands. Eur. J. Health Econ. 6(Suppl), 53–57 (2005)

4. College Tarieven Gezondsheidszorg ZorgAutoriteit: Beleidsregel ci-891, bijlage 2 ctg-zaio beleidsregel dure geneesmiddelen. http://www.nza.nl/binaries/13755/14184/14621 (2006)

5. Koopmanschap, M.A., Stolk, E.A., Koolman, X.: Dear policy maker: have you made up your mind? A discrete choice experiment among policy makers and other health professionals. Int. J. Technol. Assess. Health Care 26, 198–204 (2010)

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Under careful construction: combining findings, arguments, and values into robust health care coverage decisions;BMC Health Services Research;2022-06-07

2. National Investment Framework for Revitalizing the R&D Collaborative Ecosystem of Sustainable Smart Agriculture;Sustainability;2022-05-25

3. Which Bag? Predicting Consumer Preferences for a Luxury Product With a Discrete Choice Experiment;Australasian Marketing Journal;2021-03-18

4. Are Recently Evaluated Drugs More Likely to Receive Positive Reimbursement Recommendations in South Korea? 11-year Experience of the South Korean Positive List System;Clinical Therapeutics;2020-07

5. Differences in Health Technology Assessment Recommendations Among European Jurisdictions: The Role of Practice Variations;Value in Health;2020-01